These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12657044)

  • 1. A C-terminal EGF-like domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis.
    Brandhorst T; Wüthrich M; Finkel-Jimenez B; Klein B
    Mol Microbiol; 2003 Apr; 48(1):53-65. PubMed ID: 12657044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms.
    Finkel-Jimenez B; Wüthrich M; Klein BS
    J Immunol; 2002 Jun; 168(11):5746-55. PubMed ID: 12023375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection.
    Brandhorst TT; Wüthrich M; Finkel-Jimenez B; Warner T; Klein BS
    J Immunol; 2004 Dec; 173(12):7444-53. PubMed ID: 15585870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of non-adhesive pathogenic mechanisms of BAD1 on Blastomyces dermatitidis.
    Wüthrich M; Finkel-Jimenez B; Brandhorst TT; Filutowicz HI; Warner T; Klein BS
    Med Mycol; 2006 Feb; 44(1):41-9. PubMed ID: 16805092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin.
    Brandhorst T; Klein B
    J Biol Chem; 2000 Mar; 275(11):7925-34. PubMed ID: 10713109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism.
    Rooney PJ; Sullivan TD; Klein BS
    Mol Microbiol; 2001 Feb; 39(4):875-89. PubMed ID: 11251809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast.
    Zhang MX; Brandhorst TT; Kozel TR; Klein BS
    Infect Immun; 2001 Dec; 69(12):7559-64. PubMed ID: 11705933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis.
    Rooney PJ; Klein BS
    Eukaryot Cell; 2004 Jun; 3(3):785-94. PubMed ID: 15189999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium binding by the essential virulence factor BAD-1 of Blastomyces dermatitidis.
    Brandhorst TT; Gauthier GM; Stein RA; Klein BS
    J Biol Chem; 2005 Dec; 280(51):42156-63. PubMed ID: 16243837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis.
    Finkel-Jimenez B; Wüthrich M; Brandhorst T; Klein BS
    J Immunol; 2001 Feb; 166(4):2665-73. PubMed ID: 11160330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cell surface molecules of Blastomyces dermatitidis in the pathogenesis and immunobiology of blastomycosis.
    Klein BS
    Semin Respir Infect; 1997 Sep; 12(3):198-205. PubMed ID: 9313291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of
    McBride JA; Gauthier GM; Klein BS
    Virulence; 2019 Dec; 10(1):801-809. PubMed ID: 29532714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cell-surface molecules of Blastomyces dermatitidis in host-pathogen interactions.
    Klein BS; Newman SL
    Trends Microbiol; 1996 Jun; 4(6):246-51. PubMed ID: 8795162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion.
    Klein BS
    Curr Opin Microbiol; 2000 Aug; 3(4):339-43. PubMed ID: 10972490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis.
    Klein BS; Hogan LH; Jones JM
    J Clin Invest; 1993 Jul; 92(1):330-7. PubMed ID: 8326001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic analysis of Blastomyces dermatitidis reveals new insights about pathogenic mechanisms.
    Brandhorst TT; Rooney PJ; Sullivan TD; Klein B
    Int J Med Microbiol; 2002 Oct; 292(5-6):363-71. PubMed ID: 12452282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts.
    Hogan LH; Josvai S; Klein BS
    J Biol Chem; 1995 Dec; 270(51):30725-32. PubMed ID: 8530512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts.
    Wüthrich M; Filutowicz HI; Warner T; Klein BS
    J Immunol; 2002 Dec; 169(12):6969-76. PubMed ID: 12471131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.
    Brandhorst TT; Wüthrich M; Warner T; Klein B
    J Exp Med; 1999 Apr; 189(8):1207-16. PubMed ID: 10209038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using new genetic tools to study the pathogenesis of Blastomyces dermatitidis.
    Brandhorst TT; Rooney PJ; Sullivan TD; Klein BS
    Trends Microbiol; 2002 Jan; 10(1):25-30. PubMed ID: 11755082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.